SCICLONE PHARMACEUTICALS (HOLDINGS) LIMITED

(6600)
  Report
Delayed Hong Kong Stock Exchange  -  05/17 04:08:55 am EDT
8.720 HKD   +2.83%
04/19China Accepts SciClone Pharma's Clinical Trial Application for Neuroblastoma Immunotherapy
MT
03/29SciClone Pharmaceuticals Limited commences an Equity Buyback Plan for 67,787,426 shares, representing 10% of its issued share capital, under the authorization approved on June 16, 2021.
CI
03/25SciClone Pharma's Per-Share Earnings Slip in 2021
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news